DEF 14AThe Ballot
BIOCRYST PHARMACEUTICALS INC files DEF 14A
Filed Apr 27, 2023 · 3y ago · Accession 0001140361-23-020945
Plain English
Proxy statement — executive pay, board nominees, and shareholder votes.
Read the source below for the full document.
Filing details
- Company
- BIOCRYST PHARMACEUTICALS INC
- Ticker
- BCRX
- CIK
- 882796
- Form type
- DEF 14A
- Filing date
- Apr 27, 2023
- Report date
- —
- Document
- ny20007126x1_def14a.htm
- Size
- 7.7 MB